abstract |
The object of the present invention is to provide a use for the treatment of diseases characterized by the expression or overexpression of Aurora protein, in particular cancer. According to the present invention, a peptide that effectively inhibits the Aurora B kinase activity of INCNP that specifically binds to an Aurora protein is provided, and a pharmaceutical composition containing the peptide is provided. Also provided are a screening method for a compound that affects the interaction between the peptide and Aurora B, and a kit for screening. [Selection] None |